• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ELR基序在CXC趋化因子介导的血管生成中的功能作用。

The functional role of the ELR motif in CXC chemokine-mediated angiogenesis.

作者信息

Strieter R M, Polverini P J, Kunkel S L, Arenberg D A, Burdick M D, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D

机构信息

Department of Internal Medicine (Division of Pulmonary and Critical Medicine), University of Michigan Medical School, Ann Arbor 48109-0360, USA.

出版信息

J Biol Chem. 1995 Nov 10;270(45):27348-57. doi: 10.1074/jbc.270.45.27348.

DOI:10.1074/jbc.270.45.27348
PMID:7592998
Abstract

In this study, we demonstrate that the CXC family of chemokines displays disparate angiogenic activity depending upon the presence or absence of the ELR motif. CXC chemokines containing the ELR motif (ELR-CXC chemokines) were found to be potent angiogenic factors, inducing both in vitro endothelial chemotaxis and in vivo corneal neovascularization. In contrast, the CXC chemokines lacking the ELR motif, platelet factor 4, interferon gamma-inducible protein 10, and monokine induced by gamma-interferon, not only failed to induce significant in vitro endothelial cell chemotaxis or in vivo corneal neovascularization but were found to be potent angiostatic factors in the presence of either ELR-CXC chemokines or the unrelated angiogenic factor, basic fibroblast growth factor. Additionally, mutant interleukin-8 proteins lacking the ELR motif demonstrated potent angiostatic effects in the presence of either ELR-CXC chemokines or basic fibroblast growth factor. In contrast, a mutant of monokine induced by gamma-interferon containing the ELR motif was found to induce in vivo angiogenic activity. These findings suggest a functional role of the ELR motif in determining the angiogenic or angiostatic potential of CXC chemokines, supporting the hypothesis that the net biological balance between angiogenic and angiostatic CXC chemokines may play an important role in regulating overall angiogenesis.

摘要

在本研究中,我们证明趋化因子CXC家族根据ELR基序的有无表现出不同的血管生成活性。含有ELR基序的CXC趋化因子(ELR-CXC趋化因子)被发现是有效的血管生成因子,可诱导体外内皮细胞趋化和体内角膜新生血管形成。相比之下,缺乏ELR基序的CXC趋化因子、血小板因子4、γ干扰素诱导蛋白10和γ干扰素诱导的单核因子,不仅未能诱导显著的体外内皮细胞趋化或体内角膜新生血管形成,而且在存在ELR-CXC趋化因子或无关血管生成因子碱性成纤维细胞生长因子的情况下,被发现是有效的血管生成抑制因子。此外,缺乏ELR基序的突变白细胞介素-8蛋白在存在ELR-CXC趋化因子或碱性成纤维细胞生长因子的情况下表现出强大的血管生成抑制作用。相比之下,含有ELR基序的γ干扰素诱导的单核因子突变体被发现可诱导体内血管生成活性。这些发现表明ELR基序在决定CXC趋化因子的血管生成或血管生成抑制潜力方面具有功能作用,支持了血管生成和血管生成抑制CXC趋化因子之间的净生物学平衡可能在调节整体血管生成中起重要作用的假设。

相似文献

1
The functional role of the ELR motif in CXC chemokine-mediated angiogenesis.ELR基序在CXC趋化因子介导的血管生成中的功能作用。
J Biol Chem. 1995 Nov 10;270(45):27348-57. doi: 10.1074/jbc.270.45.27348.
2
The role of CXC chemokines as regulators of angiogenesis.CXC趋化因子作为血管生成调节因子的作用。
Shock. 1995 Sep;4(3):155-60. doi: 10.1097/00024382-199509000-00001.
3
The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity.CXC趋化因子受体2(CXCR2)是ELR+CXC趋化因子诱导的血管生成活性的假定受体。
J Immunol. 2000 Nov 1;165(9):5269-77. doi: 10.4049/jimmunol.165.9.5269.
4
The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis.CXC趋化因子,即γ干扰素诱导的单核因子,可抑制非小细胞肺癌的肿瘤生长和转移。
Hum Gene Ther. 2000 Jan 20;11(2):247-61. doi: 10.1089/10430340050015996.
5
Association between lack of angiogenic response in muscle tissue and high expression of angiostatic ELR-negative CXC chemokines in patients with juvenile dermatomyositis: possible link to vasculopathy.幼年皮肌炎患者肌肉组织中血管生成反应缺乏与血管生成抑制性ELR阴性CXC趋化因子高表达之间的关联:与血管病变的可能联系
Arthritis Rheum. 2005 Oct;52(10):3175-80. doi: 10.1002/art.21303.
6
CXC chemokines in angiogenesis relevant to chronic fibroproliferation.与慢性纤维增生相关的血管生成中的CXC趋化因子。
Curr Drug Targets Inflamm Allergy. 2005 Feb;4(1):23-6. doi: 10.2174/1568010053622902.
7
CXC chemokines in angiogenesis.血管生成中的CXC趋化因子
Cytokine Growth Factor Rev. 2005 Dec;16(6):593-609. doi: 10.1016/j.cytogfr.2005.04.007. Epub 2005 Jul 19.
8
CXC chemokines in angiogenesis.血管生成中的CXC趋化因子
J Leukoc Biol. 2000 Jul;68(1):1-8.
9
Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.监测多发性骨髓瘤患者血清中 ELR+CXC 趋化因子水平及其与微血管密度和血管生成生长因子的关系。
Cytokine. 2011 Dec;56(3):616-20. doi: 10.1016/j.cyto.2011.08.034. Epub 2011 Sep 21.
10
The ratio of ELR+ to ELR- CXC chemokines affects the lung and liver injury following hepatic ischemia/ reperfusion in the rat.ELR+与ELR- CXC趋化因子的比例影响大鼠肝脏缺血/再灌注后的肺和肝损伤。
Hepatology. 2000 Feb;31(2):435-45. doi: 10.1002/hep.510310225.

引用本文的文献

1
Staphylococcus aureus biofilm-associated component PNAG stimulates the secretion of the immunomodulatory chemokine CXCL10 via Dectin-1 signaling.金黄色葡萄球菌生物膜相关成分PNAG通过Dectin-1信号传导刺激免疫调节趋化因子CXCL10的分泌。
Commun Biol. 2025 Jul 31;8(1):1136. doi: 10.1038/s42003-025-08503-z.
2
The role of CXCL16 in atherosclerosis: from mechanisms to therapy.CXCL16在动脉粥样硬化中的作用:从机制到治疗。
Front Immunol. 2025 May 26;16:1555438. doi: 10.3389/fimmu.2025.1555438. eCollection 2025.
3
The CXCL1-CXCR2 Axis as a Component of Therapy Resistance, a Source of Side Effects in Cancer Treatment, and a Therapeutic Target.
CXCL1-CXCR2轴作为治疗抵抗的一个组成部分、癌症治疗中副作用的一个来源以及一个治疗靶点。
Cancers (Basel). 2025 May 15;17(10):1674. doi: 10.3390/cancers17101674.
4
The role of CXC chemokines and receptors in breast cancer.CXC趋化因子及其受体在乳腺癌中的作用。
Clin Exp Med. 2025 Apr 25;25(1):128. doi: 10.1007/s10238-025-01662-7.
5
Semi-synthetic fibrous fibrin composites promote 3D microvascular assembly, survival, and host integration of endothelial cells without mesenchymal cell support.半合成纤维蛋白复合材料可促进内皮细胞的三维微血管组装、存活及宿主整合,且无需间充质细胞支持。
Bioact Mater. 2025 Apr 3;49:652-669. doi: 10.1016/j.bioactmat.2025.02.029. eCollection 2025 Jul.
6
Pilot Study of Intratumoral Immunotherapy with Cowpea Mosaic Virus Nanoparticles: Safety in Refractory Canine Oral Tumors.豇豆花叶病毒纳米颗粒瘤内免疫疗法的初步研究:难治性犬口腔肿瘤的安全性
Mol Pharm. 2025 May 5;22(5):2671-2683. doi: 10.1021/acs.molpharmaceut.5c00100. Epub 2025 Apr 14.
7
Emerging immunologic approaches as cancer anti-angiogenic therapies.新兴的免疫疗法作为癌症抗血管生成治疗手段。
Clin Transl Oncol. 2025 Apr;27(4):1406-1425. doi: 10.1007/s12094-024-03667-2. Epub 2024 Sep 18.
8
Matrix stiffness-dependent regulation of immunomodulatory genes in human MSCs is associated with the lncRNA CYTOR.细胞外基质刚度依赖的人骨髓间充质干细胞免疫调节基因调控与 lncRNA CYTOR 相关。
Proc Natl Acad Sci U S A. 2024 Aug 6;121(32):e2404146121. doi: 10.1073/pnas.2404146121. Epub 2024 Jul 29.
9
Repair of the Infarcted Heart: Cellular Effectors, Molecular Mechanisms and Therapeutic Opportunities.梗死心脏的修复:细胞效应物、分子机制和治疗机会。
Circ Res. 2024 Jun 7;134(12):1718-1751. doi: 10.1161/CIRCRESAHA.124.323658. Epub 2024 Jun 6.
10
CCL18 aggravates atherosclerosis by inducing CCR6-dependent T-cell influx and polarization.CCL18 通过诱导 CCR6 依赖性 T 细胞浸润和极化加剧动脉粥样硬化。
Front Immunol. 2024 May 13;15:1327051. doi: 10.3389/fimmu.2024.1327051. eCollection 2024.